Our model not only demonstrates a state-of-the-art T2D predictive capacity that can potentially be implemented for clinical diagnostics but also provides novel biomarkers such as SACS DNA methylation that we recently linked to diabetes pathogenesis11. Here, SACS is linked to diabetes mellitus.